IN

INVO Bioscience IncNASDAQ INVO Stock Report

Last reporting period 30 Jun, 2024

Updated 21 Nov, 2024

Last price

Market cap $B

0.003

Micro

Exchange

XNAS - Nasdaq

INVO Stock Analysis

IN

Uncovered

INVO Bioscience Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-44/100

Low score

Market cap $B

0.003

Dividend yield

Shares outstanding

12.166 B

IINVO BioScience, Inc. is a fertility company. The company is headquartered in Lakewood Ranch, Florida and currently employs 10 full-time employees. The company went IPO on 2008-11-11. The firm is focused on expanding the assisted reproductive technology (ART) marketplace by making fertility care accessible and inclusive to people around the world. Its flagship product is INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. Its treatment solution is the intravaginal culture technique for the incubation of oocytes and sperm during fertilization and early embryo development. Its INVOcells inner chamber holds egg and sperm in a culture medium. Its INVO Centers offer the INVOcell and intravaginal culture (IVC) procedure, in addition to its selling of technology solutions into existing fertility clinics. The firm's subsidiaries include Bio X Cell, Inc., and Invo Centers, LLC.

View Section: Eyestock Rating